Blog Post Details

http://www.pharmacyebooks.com/2009/10/access-pharmaceuticals-provides-updat…

147 members

49,806 views per day

25,628 uniques per day

Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback

October 15, 2009

DALLAS, Oct. 15 /PRNewswire-FirstCall/ ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation Read more…

182 posts in network